These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4205800)

  • 21. [Attempt at psychometric evaluation of aging: study of a vascular drug].
    Losson M; Losson JP
    Therapeutique; 1969 Mar; 45(3):313-7. PubMed ID: 4989246
    [No Abstract]   [Full Text] [Related]  

  • 22. Electroencephalogram and ergot alkaloids.
    Venn RD
    Postgrad Med J; 1976; 52suppl 1():55-6. PubMed ID: 822408
    [No Abstract]   [Full Text] [Related]  

  • 23. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
    Brüning G
    Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mental effects of Wallerox therapy in the aged].
    Thomae H
    Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trial of eutergine in chronic cerebral arteriopathies].
    Pauchant M; Bernard JM
    Lille Med; 1972 May; 17():Suppl 4:819-23. PubMed ID: 4626797
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
    Bochner F; Eadie MJ; Tyrer JH
    J Am Geriatr Soc; 1973 Jan; 21(1):10-7. PubMed ID: 4630036
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of cerebral vascular diseases due to softening].
    Tomaselli R; Elia C
    Omnia Med Ther; 1968; 46(3):657-70. PubMed ID: 4989937
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of Iskedyl in otoneurologic ischemia].
    Duchamps B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):649-53. PubMed ID: 4280429
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of hydergine on the functional manifestations of encephalic vasomotricity].
    Memin Y; Rigal P
    Lyon Med; 1971 Jun; 225(11):1177-82. PubMed ID: 4997290
    [No Abstract]   [Full Text] [Related]  

  • 30. [Electroencephalographic findings in the course of cerebrovascular diseases in aged subjects and their changes under the influence of sympathicolytic therapy (hydergine)].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    G Gerontol; 1966 Dec; 14(12):1221-5. PubMed ID: 4966653
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of elderly patients with an effective anxiolytic drug combination].
    Hadjwasiri H
    Schweiz Rundsch Med Prax; 1973 Nov; 62(44):1383-9. PubMed ID: 4202443
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of redergam on the cerebral circulation of patients who have suffered insults].
    Khadzhiev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423
    [No Abstract]   [Full Text] [Related]  

  • 33. [Electroencephalographic and clinical study of the action of hydrogen derivatives of Ergotoxin].
    Borenstein P; Cujo P; Bahon L
    Ann Med Psychol (Paris); 1969 Oct; 2(3):410-24. PubMed ID: 4983442
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of hydergine in acute ischemic pathology of the brain].
    Gomensoro JB
    Acta Neurol Latinoam; 1967; 13(1):273-82. PubMed ID: 4976823
    [No Abstract]   [Full Text] [Related]  

  • 36. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
    Laveant-Hebrard C; Camus JP
    Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of drugs on cerebrovascular circulation with special regard to Hydergin].
    Radielović P
    Lijec Vjesn; 1971; 93(11):1227-32. PubMed ID: 5005614
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of hydergine on the transit time of cerebral circulation in diffuse cerebral insufficiency.
    Mongeau B
    Eur J Clin Pharmacol; 1974; 7(3):169-75. PubMed ID: 4212405
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experiences with gerontotherapeutic agent Wallerox (GN 468)].
    Voegt H; Haid E
    Med Klin; 1970 Nov; 65(46):2031-5. PubMed ID: 5000077
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interpretation of the clinical signs in the light of recent acquisitions].
    Heyck H
    Minerva Med; 1968 Dec; 59(96):5200-6. PubMed ID: 4974812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.